Searchable abstracts of presentations at key conferences in endocrinology

ea0029p325 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Analysis of hyponatremia in a tertiary hospital during a 5 year period

Duran A. , Gomez E. , Molino A. , Granda C. , Marco J.

Aims: Hiponatremia is the most frequent electrolyte disturbance. Our aim is to retrospectively analyze the diagnosis of hyponatremia in the discharge sheets of a tertiary hospital during 5 yearsMethod: Data from the MBDS (Minimum Basic Data Set) of the discharged patients from the Hospital Clínico San Carlos (Madrid) between the years 2005 and 2009 was analysed. The 5th Edition of the ICD-9-CM was used for the codification of the diagnoses and proce...

ea0041oc2.2 | Receptors & Signalling | ECE2016

Expression levels of thyroglobulin processing proteases are reduced upon trace amine-associated receptor 1 deficiency in mice

Szumska Joanna , Batool Zaina , Qatato Maria , Gavilanes Emily Melisa Ullrich , Skripnik Vladislav , Shillova Nita , Grandy David K. , Brix Klaudia

The function of the thyroid gland is to maintain thyroid hormone (TH) levels in the blood circulation. Thyroid epithelial cells liberate TH from the precursor molecule thyroglobulin (Tg) by the combined proteolytic action of the cathepsin B, K, L, and S. Cathepsin L-deficiency in mice results in impaired processing of Tg and remnants of dead cells in the follicle lumen. Recently, we have shown that Trace amine-associated receptor 1 (Taar1) is localized on the primary cilia of ...

ea0014oc10.6 | Obesity & metabolism | ECE2007

3-Iodothyronamine (T1AM) is a novel modulator of metabolic rate and glucose homeostasis

Grandy David K. , Suchland Katherine L. , Keck Thomas M. , Yan Feifei , Shyng Show-Ling , Scanlan Thomas S.

3-Iodothyronamine (T1AM) is a novel endogenous derivative of thyroid hormone (TH), recently described by Scanlan et al. (Nat. Med. 10: 638, 2004). In vitro, T1AM can stimulate the production of cAMP via activation of a heterologously expressed G protein-coupled receptor (GPCR) now referred to as trace amine-associated receptor 1 (TAAR1; Lindemann et al. Genomics 85: 372, 2005). In adult, unanesthetized C57Bl6/J mice, T1AM produces prof...

ea0081rc1.2 | Rapid Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2022

Glucose alterations, insulin resistance, hypertension, and activation of the renin-aldosterone system are strictly associated in pediatric obesity

Antoniotti Valentina , Amore Martina , Bellone Simonetta , Ricotti Roberta , De Grandi Roberta , Caputo Marina , Spadaccini Daniele , Mancioppi Valentina , Aimaretti Gianluca , Prodam Flavia

Background: The increase of global childhood obesity has led to an increase of associated co-morbidities also at a young age. The pro-inflammatory state and insulin resistance are two master regulators of several complications, including hypertension and pre-diabetes frequently connected in a complex cross-talk.Aim: To evaluate the relationship between glucose alterations and blood pressure and the pathogenetic involvement of the renin-aldosterone system...

ea0063p446 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Prevalence of non-carcinoid syndrome (non-CS) diarrhoea in patients with neuroendocrine tumours (NETs): a systematic literature review (SLR)

Khan Mohid S , Walter Thomas , Buchanan-Hughes Amy , Keeber Lucie , Feuilly Marion , Grande Enrique

Background: Approximately 20% of NET patients develop CS, characterised by diarrhoea and flushing. However, CS is not the only cause of diarrhoea among NET patients. Non-CS causes should be considered to allow for appropriate management. We investigated the reported occurrence of diarrhoea from various non-CS causes in patients with gastroenteropancreatic NETs (GEP-NETs), to explore the need for differential diagnosis (DDx) of NET diarrhoea.Methods: MEDL...

ea0049ep784 | Endocrine tumours and neoplasia | ECE2017

Multidisciplinary committee on endocrine tumors: an analysis of 6-year experience

Diez Juan J , Iglesias Pedro , Alonso-Gordoa Teresa , Grande Enrique , Gajate Pablo

Aim: Multidisciplinary approach is mandatory in the management of endocrine tumors. Herein, we summarize the healthcare activity performed during the last 6 years at the multidisciplinary committee for endocrine tumors of a tertiary and University Hospital.Methods: A search of clinical-care activity of the endocrine tumors committee of our hospital from 2011 to 2016 was performed. Clinical and demographic data of all patients were recorded. The committee...

ea0032p712 | Neuroendocrinology | ECE2013

Effects of GH therapy in carbohydrate metabolism in spanish adults with GH deficiency

Andrea Parra Ramirez Paola , Perez Fernandez Laura , Fernandez Martinez Alberto , Grande Aragon Cristina , Alvarez-Escola Cristina

GH deficiency (GHD) in adults is characterized by a tendency towards fat mass gain and may predispose to type 2 diabetes mellitus.GH replacement (GHR) is associated with impaired insulin sensitivity shortly after starting therapy, reflected by increased fasting glucose and insulin levels. Available evidence suggests that concerns regarding glucose intolerance in patients receiving long-term GHR have not been substantiated. However, several environmental and lifestyle-related f...

ea0026p86 | Endocrine tumours and neoplasia | ECE2011

Role of peptide receptor radionuclide therapy (PRRT) in well and moderately differentiated neuroendocrine tumours

Bianchi A , Milardi D , Iacovazzo D , Tartaglione L , Grande G , Piacentini S , Pontecorvi A , De Marinis L

PRRT is a treatment choice for inoperable or metastasized neuroendocrine tumours and this therapy seems more effective in the biochemical and volume control of disease than SSA. We investigated the role of medical therapy with SSA and PRRT in patients with well and moderately differentiated neuroendocrine tumours. We evaluated 55 patients with well or moderately differentiated neuroendocrine tumours; 31 patients with either metastatic, unresectable or functioning tumours were ...

ea0026p726 | Diabetes (epidemiology, pathophysiology) | ECE2011

Effects of the ghrelin gene products on glucose metabolism in C2C12 muscle cells

Grande Cristina , Settanni Fabio , Gesmundo Iacopo , Taliano Marina , Ghigo Ezio , Granata Riccarda

Type II diabetes is a clinical disorder of glucose and fat metabolism, caused by an inability of insulin to promote sufficient glucose uptake into adipose tissue and striated muscle and to prevent glucose output from the liver. Skeletal muscle is an important element for the maintenance of glucose homeostasis because it can increase, after stimulation, glucose uptake from the blood. In previous experiments we found that acylated ghrelin (AG), unacylated ghrelin (UAG), obestati...

ea0022p180 | Clinical case reports and clinical practice | ECE2010

Papillary thyroid carcinoma in a patient with intestinal ganglioneuromatosis

Boillos Margarita Gonzalez , Monte Zhuraida Salman , Grande Eladio Jose Losada , Caudet Ines , Lopez Paula

A 16-years-old male, with familiar precedents of familiar macrocephaly, he has been visited in external consultations of digestive in 2008 because he had rectal bleedings. A colonoscopy was made two times, in those situations some intestinal polyps have been extirpated. The result of the pathological antomy was polyps ganglioneuromas.Due to the pathological compatible anatomy with ganglioneuromas, it stemmed to external consultations of endocrinology to ...